Target intelligence / Profile preview

Trace amine-associated receptor 9 (TAAR9)

Target
TAAR9
Molecular classification
G protein-coupled receptor, Receptor, Olfactory receptor (noncanonical subclass)
01

Overview

Trace amine-associated receptor 9 (TAAR9) is a rhodopsin-like G protein-coupled receptor with seven transmembrane domains, primarily known for detecting trace amines and volatile amine compounds in the olfactory system[1][2][4][7]. TAAR9 mediates signal transduction through G proteins, integrating chemical cues that may influence behavior and physiological responses such as lipid metabolism (e.g., affecting low-density lipoprotein cholesterol)[1]. Its endogenous ligands include polyamines and certain monoamines, and its activity involves complex ligand entry and binding mechanisms, including multiple entry tunnels and pockets within the receptor structure[2]. TAAR9, along with related TAAR family members, is being investigated as a potential therapeutic target for metabolic and inflammatory disorders, though clinical data are currently limited[7]. \n\nIf further granularity is needed for disease or drug information, continued research in the TAAR9 field is warranted due to currently limited ligand and expression profiling.

Other names
Trace amine receptor 9TAAR9TaR-9TAR9TRAR3TA3TAR3Trace amine receptor 3trace amine-associated receptor 9trace amine receptor 3
02

Mechanism of action

Agonists activate TAAR9 via binding to orthosteric and vestibular pockets, resulting in intracellular signaling through heterotrimeric G proteins typical of GPCRs\nAntagonists inhibit receptor activation, potentially interfering with physiological responses

03

Biological functions

Signal transductionRecognition of volatile aminesOlfactory (chemosensory) receptionPotential metabolic regulation
04

Disease associations

Metabolic disorders (e.g., lipid regulation, impact on LDL cholesterol)Potential inflammatory responsesPossible roles in neuropsychiatric disease (by analogy with TAAR1)
05

Safety considerations

Limited data on safety profile; low expression in most tissues may reduce off-target effectsPotential for olfactory/behavioral side effects if targeted for therapy
06

Interacting drugs

N-methyl piperidine (agonist)

4 more in the full profile.

Beyond the preview

Go deeper on Trace amine-associated receptor 9 (TAAR9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trace amine-associated receptor 9 (TAAR9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call